While strategies such as chemotherapy and immunotherapy have become the first-line
standard therapies for patients with advanced or metastatic cancer, acquired resistance is …

Breast cancer is a significant cause of cancer-related mortality in women worldwide. Early
and precise diagnosis is crucial, and clinical outcomes can be markedly enhanced. The rise …

Importance The association of tumor-infiltrating lymphocyte (TIL) abundance in breast
cancer tissue with cancer recurrence and death in patients with early-stage triple-negative …

Cancer has a high mortality rate across the globe, and tissue biopsy remains the gold
standard for tumor diagnosis due to its high level of laboratory standardization, good …

Triple-negative breast cancer (TNBC) accounts for 15–20% of all breast cancers and is
characterized by an aggressive nature and a high rate of recurrence despite neoadjuvant …

Abnormal alterations in human epidermal growth factor receptor 2 (HER2, neu, and erbB2)
are associated with the development of many tumors. It is currently a crucial treatment for …

Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer
worldwide, with an estimated 2.3 million new cases (11.7%), followed by lung cancer …

Background Adjuvant breast radiotherapy as a standard component of breast-conserving
treatment for early cancer can overtreat many women. Breast MRI is the most sensitive …

Endocrine therapy is one of the standard adjuvant treatments to reduce the risk of
recurrence and mortality in patients with hormone receptor positive early breast cancer …

Importance The increasing use of neoadjuvant systemic therapy (NST) has led to substantial
pathological complete response rates in patients with initially node-positive, early breast …